diabetestalk.net

Diabetes Treatment In Bangladesh

Awareness, Treatment, And Control Of Diabetes In Bangladesh: A Nationwide Population-based Study

Awareness, Treatment, And Control Of Diabetes In Bangladesh: A Nationwide Population-based Study

Awareness, Treatment, and Control of Diabetes in Bangladesh: A Nationwide Population-Based Study 2Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan 4Department of Population Science and Human Resource Development, University of Rajshahi, Rajshahi, Bangladesh 3Department of Global Health Policy, University of Tokyo, Tokyo, Japan 4Department of Population Science and Human Resource Development, University of Rajshahi, Rajshahi, Bangladesh Jeremy D Goldhaber-Fiebert, Academic Editor 1Department of Public Health, First Capital University of Bangladesh, Chuadanga, Bangladesh 2Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan 3Department of Global Health Policy, University of Tokyo, Tokyo, Japan 4Department of Population Science and Human Resource Development, University of Rajshahi, Rajshahi, Bangladesh Competing Interests: The authors have declared that no competing interests exist. Conceived and designed the experiments: MSR SA MMR. Performed the experiments: MSR SA MMR. Analyzed the data: MSR SA MMR. Contributed reagents/materials/analysis tools: MSR SA MMR. Wrote the paper: MSR SA. Critical revision and discussion: SKA MRI MNIM JAMSR MMR. These authors are co-first authors on this work. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited This article has been cited by other articles in PMC. To examine awareness, treatment, and control of diabetes mellitus among the adult population in Bangladesh. The study used data from the Continue reading >>

A Survey On Practice And Treatment Towards Diabetes Mellitus Of Diabetic Patients In Bangladesh Perspective

A Survey On Practice And Treatment Towards Diabetes Mellitus Of Diabetic Patients In Bangladesh Perspective

A Survey on Practice and Treatment Towards Diabetes Mellitus of Diabetic Patients in Bangladesh Perspective JavaScript is disabled for your browser. Some features of this site may not work without it. A Survey on Practice and Treatment Towards Diabetes Mellitus of Diabetic Patients in Bangladesh Perspective Diabetes mellitus is a rapidly growing disease around the world., About 387 million people have diabetes worldwide. This is equal to 8.3% of the adult population, with equal rates in both women and men. In the years 2012 to 2014, diabetes is estimated to have resulted in 1.5 to 4.9 million deaths per year. In Bangladesh, the number diabetic patient has also increased due to lack of in appropriate practice and treatment. There is little work done on diabetes mellitus as well as practice and treatment towards Diabetes mellitus of diabetic patients in Bangladesh. The main objective of our study was to see the recent consequences of practice and treatment pattern of Diabetes mellitus. It was a survey based study and performed on 202 diabetic patients in BIRDEM (Bangladesh Institute of Research and Rehabilitation for Diabetes, Endocrine and Metabolic Disorders) at Shahbag, Dhaka, BIRDEM at Rampura, Dhaka and Sangshad Vaban park. In this study 51.44% male and 48.55% female participants were found. Patients were selected randomly. Here common factors are considered affecting diabetes practice and treatment pattern were sex, age, level of education, marital status, profession, and income, mode of diagnosis and duration of diabetes. Only Diabetic patients were selected as study population. 96.53% of them were married and 3.96% were single. The study also showed that the maximum percentage (20.79%) of normal range of fasting blood glucose level was 4.1-6 mg/ml and the maximum Continue reading >>

Diabetes And Holistic System Of Treatment

Diabetes And Holistic System Of Treatment

8 November, 2017 11:56:14 AM / LAST MODIFIED: 8 November, 2017 11:56:55 AM Diabetes and holistic system of treatment Maintaining healthy lifestyle for controlling diabetes has been emphasized around the world It has been possible to suessfully control diabetes within short time through alternative system. Patients either have been able to avoide insulin or reduce half the amount of insulin three days within the beginning of natural treatment. Two three-day workshops on control of diabetes were held in the capital on August and September this year when participants got the first-hand knowledge about the alternative system of treatment and they also followed the rules of the system. There were good results observed among the patients. Successful stories of some of the patients, who were benefitted, are mentioned below. Aftab Mia, a businessman of Sylht, used to take 126 units of insulin in total and two other tablets. Desite it, his blood sugar level was 12-15. He used to spend Tk. 55,000 for buying insulin and medicine every month. While attending a three-day workshop, he was able to control his sugar without insulin and medicine. At present, his blood sugar level is 8-10. Monwar Hossain Chowdhury, an official of Chittagong Customs House, used to take 100 insulins in total and his blood sugar level hovered between 10 to 12. He has also been able to shun insulin and his blood sugar level is now between 7-8. Engineer Monindra Nath Bain has been suffering from disbetes and high blood pressure for a long time. He used to take a lot of medicine and his blood sugar level stayed between 15 to 20. He also could shun his medicine, now his blood sugar level has been reduced and it remains between 6-8. Bharati Roy, a school teacher by profession, has five blockages in her heart. B Continue reading >>

Diacare: Diabetes Medicine Store And Diabetes Care, Dhaka, Bangladesh

Diacare: Diabetes Medicine Store And Diabetes Care, Dhaka, Bangladesh

Please check if delivery is available in your locality before checking out. You may talk to DIACARE helpline (+8809666776633) for assistance. From answering simple questions all the way to any query, we're here to help you online or on the phone.. All transaction passed between customer and our system is encrypted. You can be completely assured that none of your information can be used or modified by any third parties within our system. We strictly maintain cold chain & ensure genuine product collected directly from the manufacturer.Please check the product while delivery.Return is not acceptable after delivery. *You must upload "Prescription" while checkout or show the prescription to the delivery assistant.Otherwise, we won't deliver it to you. DiaCare always with you to help whether you have recently been diagnosed, having trouble controlling your blood glucose levels or simply want to have your necessary/prescribed medications in your doorsteps. DIACARE, 2nd Floor, Dhanmondi Tower, House-4/A, Road-16 (Old-27), Dhanmondi, Dhaka , Dhaka Bangladesh Continue reading >>

Why Is Diabetes On The Rise In Bangladesh?

Why Is Diabetes On The Rise In Bangladesh?

Why Is Diabetes On The Rise In Bangladesh? Bangladesh has a disproportionately high diabetes population with more than 7.1 million, 8.4% of the adult population affected by the disease. According to research published in WHO bulletin in 2013, it is more than 10 million. The number will be 13.6 million in 2040, predicts several sources including IDF Diabetes Atlas. Nearly half of the population with diabetes, 51.2%, dont know that they have diabetes and dont receive any treatment. Bangladesh is home to a 161 million population, according to the latest census report. During 90s, the country has a relatively low diabetes affected population. In 1995, it was only 4% which grew to 5% in 2000 and 9% during the period 2006 to 2010. According to the International Diabetes Federation, the prevalence will be 13% by 2030. The most alarming news is that a growing number of children and young people are developing diabetes. There are a couple of reasons behind this rapid growth of diabetes in Bangladesh. Dr. Shahjada Selim, an Assistant Professor at Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, says lack of awareness, inconsiderate lifestyle, and lack of preventative initiatives from the government are among the major reasons behind this growth. Dr. Selim goes on: Bangladesh is among the most vulnerable countries Bangladesh currently is among the countries that are considered to be most vulnerable to diabetes. That is not to say that the prevalence rate of diabetes in our country is very high. Saudi Arabia has a 25.4% prevalence rate and Beirut 34.75%. Till date, we are only at 8.4%. The problem though is that the prevalence rate is dropping every year in those other countries, whereas, it is on the rise in Bangladesh. Along with lifestyle reasons, we ge Continue reading >>

Methi Dust In Diabetes Treatment

Methi Dust In Diabetes Treatment

Published: 2006-01-23 18:00:00.0 BdSTUpdated: 2006-01-23 18:00:00.0 BdST Fenugreek seeds, also known as Methi dust shrinks rate of blood and urine sugar in Diabetics, Scientists of the NIN of Hyderabad have claimed after conducting extensive experiments in the nineties. Dhaka, Jan 23 (BDNEWS)- Fenugreek seeds, also known as Methi dust shrinks rate of blood and urine sugar in Diabetics, Scientists of the NIN of Hyderabad have claimed after conducting extensive experiments in the nineties. It was proved in the experiment that 50 grams of Methi dust could control blood sugar as much as a diabetes medicine, for example, 250 mg of Chlorpropamide does. Moreover, Methi works in case of general diabetes as well as in insulin based diabetes. Vegetables of Fenugreek cannot be compared to its seeds while seeds contain 50 percent of dietary fibre. Methi weigh downs blood sugar inclination resulted by sugar's inhalation power. Additionally, Trigonelin of Methi also reduces blood sugar, the study says. Methi further cuts off rate of cholesterol and Trygliceride in blood. As Methi contains a lot of dietary fibres, it can also check heart attack possibility in the body of a coronary heart disease infected patient. Methi dust can be taken with food twice a day as much as two spoon. Hyderabad nutritionists have invented hundreds of food recipes mixed with Fenugreek dust. Any person having diabetes can take Methi dust up to 50 grams with bread, rice, or pulse everyday. The ratio of taking Methi needs to increase gradually side-by-side taking medicines in primary stage. It results in reduction of medicines as blood and urine sugar decline by Methi. Methi dusts however act far better in the case of primary infected (type two) diabetes patients. Still the inventors do not claim the use of M Continue reading >>

Tuberculosis Co-morbidity With Diabetes Mellitus In Bangladesh: Prevalence And Treatment Outcomes In Urban And Rural Settings

Tuberculosis Co-morbidity With Diabetes Mellitus In Bangladesh: Prevalence And Treatment Outcomes In Urban And Rural Settings

Tuberculosis co-morbidity with diabetes mellitus in Bangladesh: prevalence and treatment outcomes in urban and rural settings Tuberculosis co-morbidity with diabetes mellitus in Bangladesh: prevalence and treatment outcomes in urban and rural settings In 2012, the World Health Organization ranked Bangladesh as the 6th highest tuberculosis (TB) burdened country in the world. As a highly contagious disease, tuberculosis poses a significant public health challenge to Bangladeshs TB control especially when comorbid with Diabetes Mellitus (DM), a disease which suppresses the immune system in humans. The rise in DM means a growing percentage of the population face an increased risk of reactivation of latent TB infections. Moreover, underlying DM may adversely affect the success of TB treatment in patients, and vice versa. Before taking corrective action, a thorough analysis of TB-DM prevalence, distribution, and baseline treatment outcomes is needed. There is a large gap in the literature regarding prevalence of DM in TB patients in rural and urban areas. In addition, there is little information regarding treatment outcomes of TB in patients with DM in Bangladesh. Therefore, this study aimed to fill the existing gap in literature and help build stronger policies regarding tuberculosis control, and in turn improve the services provided by TB control programmes in Bangladesh. The study conducted oral glucose tolerance test (OGTT) of 1,910 TB patients in 16 districts of Bangladesh to gather information about their DM status. While undergoing the OGTT, the patients were also interviewed using a structured questionnaire, and their height and weight were measured to calculate their body mass index (BMI). The study also followed up with 750 patients after they had completed their t Continue reading >>

Novo Nordisk Launches New Diabetes Drug In Bangladesh

Novo Nordisk Launches New Diabetes Drug In Bangladesh

Prof AK Azad Khan, third from right, president of Diabetic Association of Bangladesh, Svend Olling, second from right, Danish ambassador to Bangladesh, and Sanjeev Shishoo, extreme left, a vice president of Novo Nordisk, pose at the launch of Novo Nordisk's novel type 2 diabetes drug Victoza at Ruposhi Bangla Hotel in Dhaka yesterday. Photo: STAR Novo Nordisk, one of the world's leading companies in diabetes care, yesterday launched its novel type 2 diabetes drug Victoza in Bangladesh. Victoza, a once-daily liraglutide injection, has been proven to lower blood sugar levels, reduce body weight, lower systolic blood pressure, and shows improvements in measurements of beta cell function. It comes at a time when the number of diabetic population is increasing in Bangladesh at an alarming rate due to changes in lifestyle, obesity, lack of physical work and ageing of people. At present, the diabetic population number in the country is 8.4 million, which is expected to double by 2030, according to International Diabetes Federation. Victoza was developed for the treatment of type 2 diabetes in adults, and is indicated in people with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin or sulphonylurea. Our goal for the development of Victoza was to find the best way to help people with type 2 diabetes maintain control over their glucose levels with reduced risk of hypoglycaemia, said Sanjeev Shishoo, vice president of Novo Nordisk Oceania and South East Asia region. Shishoo spoke at the launch at Ruposhi Bangla Hotel in Dhaka. With Liraglutide, patients with type 2 diabetes can be confident that they are controlling their blood sugar, and may benefit from weight loss, said Prof AK Azad Khan, president of Diabetic Association of Bangladesh Continue reading >>

Awareness, Treatment, And Control Of Diabetes In Bangladesh: A Nationwide Population-based Study.

Awareness, Treatment, And Control Of Diabetes In Bangladesh: A Nationwide Population-based Study.

Awareness, treatment, and control of diabetes in Bangladesh: a nationwide population-based study. Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. More Department of Population Science and Human Resource Development, University of Rajshahi, Rajshahi, Bangladesh. More Department of Global Health Policy, University of Tokyo, Tokyo, Japan; Department of Population Science and Human Resource Development, University of Rajshahi, Rajshahi, Bangladesh. More 1.Department of Public Health, First Capital University of Bangladesh, Chuadanga, Bangladesh. 2.Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. 3.Department of Global Health Policy, University of Tokyo, Tokyo, Japan. 4.Department of Population Science and Human Resource Development, University of Rajshahi, Rajshahi, Bangladesh. 5.Department of Global Health Policy, University of Tokyo, Tokyo, Japan; Department of Population Science and Human Resource Development, University of Rajshahi, Rajshahi, Bangladesh. To examine awareness, treatment, and control of diabetes mellitus among the adult population in Bangladesh.The study used data from the 2011 nationally representative Bangladesh Demographic and Health Survey (BDHS). The BDHS sample is comprised of 7,786 adults aged 35 years or older. The primary outcome variables were fasting blood glucose, diagnosis, treatment, and control of diabetes. Multilevel logistic regression models were used to identify the risk factors for diabetes awareness.Overall, age-standardized prevalence of diabetes was 9.2%. Among subjects with diabetes, 41.2% were aware of their condition, 36.9% were treated, and 14.2% controlled Continue reading >>

Diabetes Pills

Diabetes Pills

Many types of diabetes pills can help people with type 2 diabetes lower their blood glucose. Each class of pill helps lower blood glucose in a different way. You might know your pill (or pills) by a different name. Each of the medicines discussed here has side effects and other warnings and precautions. Some diabetes pills have been associated with increased risk of heart disease. It is important to discuss the risks and benefits of a drug with your doctor before starting any therapy. Sulfonylureas These pills do two things: Help your pancreas make more insulin. Help your body use the insulin it makes. For these pills to work, your pancreas has to make some insulin. Generic names for some of the more common sufonylureas are glimepiride, glyburide, chlorpropamide, and glipizide. Some sulfonylureas work all day, so you take them only once a day - usually before breakfast. Others you take twice a day, typically before breakfast and before supper. Your doctor will tell you how many times a day you should take your diabetes pill(s). Some possible side effects include low blood glucose (hypoglycemia), upset stomach, skin rash or itching, and/or weight gain. Biguanides Known under the generic name metformin (met-FOR-min), this drug helps lower blood glucose by making sure your liver does not make too much glucose. Metformin also lowers the amount of insulin in your body. Metformin can improve blood fat and cholesterol levels. Also, metformin does not cause blood glucose to get too low (hypoglycemia) when it is the only diabetes medicine you take. Regular metformin is taken 2 to 3 times a day, with meals. Your doctor will tell you which meals to take it with. There is an extended release version of metformin which is taken once a day. Some possible side effects of metformin inc Continue reading >>

Bangladesh National Guidelines On The Management Of Tuberculosis And Diabetes Mellitus Co-morbidity (summary) Hossain Md, Ahmed Ju, Rahim Ma, Musa A, Latif Za - Indian J Endocr Metab

Bangladesh National Guidelines On The Management Of Tuberculosis And Diabetes Mellitus Co-morbidity (summary) Hossain Md, Ahmed Ju, Rahim Ma, Musa A, Latif Za - Indian J Endocr Metab

The association between diabetes mellitus (DM) and tuberculosis (TB) and their synergistic role in causing human diseases has been recognized for centuries. DM is not only a risk factor for TB but also influences the disease presentation and treatment response. On the other hand, TB/anti-TB medications might induce glucose intolerance or worsen glycemic control in people with DM. We have a national guideline for the management of TB, with some highlights on the treatment of TB in some co-morbid conditions, but a detailed guideline is lacking. Thus, physicians often face difficulties in treating TB with other co-morbidities, particularly DM, kidney, and liver disease, especially regarding drug selection and dosage in patients with renal and hepatic impairment, duration of anti-tubercular treatment and follow-up in DM patients. Recently, the World Health Organization (WHO) and the International Union against Tuberculosis and Lung Disease have acknowledged the need for international guidelines on the joint management and control of TB and DM and have published a provisional collaborative framework for the care and control of both diseases. [1] This guideline was developed as part of the Bangladesh Diabetic Samity (BADAS)-USAID TB Care II project, Bangladesh, for the management of patients with TB-DM co-morbidity. The basis of this guideline is the existing National Guidelines and Operational Manual for TB Control (5th edition). Along with that, guidelines for management of DM as per WHO and International Diabetes Federations were followed. To develop this guideline, two workshops were arranged with the participation of public health experts and renowned clinicians from concerned specialties of different institutions of the country. An extensive online search through Medli Continue reading >>

Gestational Diabetes Mellitus- Experience In Bsmmu, Bangladesh | 51951

Gestational Diabetes Mellitus- Experience In Bsmmu, Bangladesh | 51951

South-East Asia has the highest prevalence of hyperglycemia in pregnancy (24.2%). Screening for gestational diabetesmellitus (GDM) is important owing to adverse fetal and maternal outcomes and risk of developing diabetes in future.Different methods of screening have hindered the development of a universal diagnostic criterion for GDM. An alarmingfrequency of GDM in Bangladeshi population following World Health Organization (WHO) 1999 and WHO 2013 diagnosticcriteria respectively (36.6% and 40.9%) was observed. Comparison of WHO 1999, modified OSullivan and WHO 2013 criteriafor GDM revealed discrepancy among these criteria despite good agreement. We observed higher frequency of risk allele,TCF7L2 rs7903146 in Bangladeshi GDM mothers under pilot study. Association was stronger in women having lower age andbody mass index (BMI). Postpartum persistence of abnormal glucose tolerance (AGT) in GDM was also higher (50%); AGTin early gestation, use of insulin during pregnancy, higher maternal age and BMI were predictors for it. Adverse events wererelatively higher in mothers with AGT than those with normal glucose tolerance (NGT) despite treatment (not significant).Implementation of 03-sample OGTT in resource poor setting is difficult. We are comparing diagnostic efficiency of simplerDiabetes in Pregnancy Study Group India (DIPSI) criterion with intention to implement for screening of GDM in communitylevel. The extent of thyroid dysfunction in mothers with GDM is also being evaluated by our group. Multinational broad-basedcomparative studies are needed to explore the genetic predisposition and risk factors for GDM among the ethnic groups ofdifferent countries in Asia. M A Hasanat has completed his MPhil in 1990 and MD (Endocrinology and Metabolism) in 1997 from Bangladesh Instit Continue reading >>

Who | Prevalence Of Diabetes And Prediabetes And Their Risk Factors Among Bangladeshi Adults: A Nationwide Survey

Who | Prevalence Of Diabetes And Prediabetes And Their Risk Factors Among Bangladeshi Adults: A Nationwide Survey

Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey Shamima Akter a, M Mizanur Rahman b, Sarah Krull Abe b & Papia Sultana c a. Department of Epidemiology and Prevention, Clinical Research Center, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-ku, Tokyo 162-8655, Japan. b. Department of Global Health Policy, University of Tokyo, Tokyo, Japan. c. Department of Statistics, University of Rajshahi, Rajshahi, Bangladesh. Correspondence to Shamima Akter (e-mail: [email protected] ). (Submitted: 02 August 2013 Revised version received: 17 November 2013 Accepted: 19 November 2013 Published online: 10 January 2014.) Bulletin of the World Health Organization 2014;92:204-213A. doi: Diabetes mellitus is a leading cause of death and disability worldwide. 1 , 2 Its global prevalence was about 8% in 2011 and is predicted to rise to 10% by 2030. 3 Nearly 80% of people with diabetes live in low- and middle-income countries. 3 Asia and the eastern Pacific region are particularly affected: 3 8 in 2011, China was home to the largest number of adults with diabetes (i.e. 90.0 million, or 9% of the population), followed by India (61.3 million, or 8% of the population) and Bangladesh (8.4 million, or 10% of the population). 3 However, many governments and public health planners remain largely unaware of the current prevalence of diabetes and prediabetes, the potential for a future rise in prevalence and the serious complications associated with the disease. Consequently, knowledge of the prevalence of diabetes and prediabetes and of related risk factors could raise awareness of the disease and lead to new policies and strategies for prevention and management. In Bangladesh, which had a population of 149.8 milli Continue reading >>

A Review Of Five Traditionally Used Anti-diabetic Plants Of Bangladesh And Their Pharmacological Activities - Sciencedirect

A Review Of Five Traditionally Used Anti-diabetic Plants Of Bangladesh And Their Pharmacological Activities - Sciencedirect

A review of five traditionally used anti-diabetic plants of Bangladesh and their pharmacological activities Author links open overlay panel Md. RajdoulaRafe Open Access funded by Hainan Medical College Plants are used traditionally throughout the globe to treat various diseases. Traditionally used medicinal plants are an essential part of the health sector in Bangladesh due to its abundance of a vast source of ethno-medicine. Rural people from developing country like Bangladesh are greatly dependent on traditional source of medicine. The prevalence of diabetes mellitus is increasing from recent years; therefore various researches are going on to discover better medicine to treat this disease. This study has focused on five plants which are Andrographis paniculata, Ageratum conyzoides, Swertia chirata, Terminalia arjuna, and Azadirachta indica to find out their traditional formulation as anti-diabetic medicine and their pharmacological activity has also been explored through literature search. The available information about traditional anti-diabetic uses of these plants and their pharmacological activities were collected from various electronic sources like Pubmed, SciFinder, Elsevier, Springer, Scopus, Scirus, Science Direct, Google Scholar and Web of Science apart from these locally available books and peer reviewed journal were also used to collect information. This study will help to strengthen the relation between traditional medicine, pharmacology and drug development. A clue may be found from the information provided this review to discover new and better anti-diabetic drugs. Continue reading >>

Diabetes Disease : Sign And Symptom, Prevention, Treatment In Bangla And English

Diabetes Disease : Sign And Symptom, Prevention, Treatment In Bangla And English

1. Frequent urination-sometimes almost hourly. 6. In women, frequent yeast and bladder infections, sometimes missed menses. 1. Take advice from a doctor specialized in Diabetes, if you know or suspect that you have diabetes. 2. Follow your doctors advice about diet, exercise, and monitoring your blood sugar levels. 1. If you feel weak and nauseous, excessively thirsty, are urinating very frequently, rapid breathing, and have abdominal pain. 2. If you experience extreme thirst, lethargy, weakness and mental confusion; you may have dangerously high blood sugar levels that could lead to coma. 3. If a person known to have diabetes loses consciousness. 4. If you have noticeable sweet smelling breath along with the symptoms listed above, you may have ketoacidosis-a life-threatening condition. 1. If you or your child develop symptoms of diabetes. 2. If you have diabetes and you get flu; flu and some other illness can make your blood sugar levels go out of control. 1. There is no way prevent Type I diabetes. 1. Keep your weight within the healthy range for your age, height and structure. 2. Exercise regularly. It is very crucial in preventing diabetes or managing it once it occurs. 3. If you are over 40, and overweight, or have a family history of diabetes, check up for diabetes every one to three years. 1. gwk gwk eowg pItw - iwS ic ewt exZ NUwt pItw| 2. pVwu Kk AwZ KwkY bxpK IRd Ki jwItw| 3. ewxdk Znw gx ewItw xKvgw AxZxk Znw ewItw| 6. dwkybk q gwk gwk BU gw QwKNxUZ Ggv idwly gw gwWwkk BdfKmd gw ovwiK kwM pItw KLdI KLdI iwxoK dw pItw 1. Awedwk jxb id pt j Awexd WwtwgxUo Aww ptQd oq WwtwgxUo-Gk xgmn Wwwkk ekwim xdd 2. Wwwkk ekwim Adjwty Awedwk Lwb ZwxlKw id Pld, xdtxiZ mkyk PPw Kkd Ggv bpk k oMwk gw xPxdk exkiwY xK o ovw Zalw ejgqY Kkd 1. jxb Awedwk Kwx lwM Ggv xgZnwgwc hwMd, Continue reading >>

More in diabetes